Trimester dependent preterm births in pregnancy with genital herpes

• Authors: Ferenc Bánhidy , István Dudás , Andrew Czeizel
• Languages of publication: EN

Abstracts

EN

Previous studies reported controversial results regarding the possible association of recurrent genital herpes during pregnancy with a higher risk of preterm birth/low birth weight in newborns. Thus, birth outcomes of mothers with prospective and medically recorded symptomatic recurrent genital herpes confirmed by serological examination and of mothers without genital herpes were compared in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities. Our results showed that of 38,151 newborn infants, 86 (0.23%) had mothers with symptomatic recurrent genital herpes confirmed by serological examination during pregnancy. The rate of preterm births (14.0% vs. 9.2%) was higher in babies born to mothers with symptomatic recurrent genital herpes (OR with 95% CI: 1.7, 1.0–3.1) and this increase showed a trimester dependence with the highest rate in the third trimester (23.5%; OR with 95% CI: 2.6, 1.5–4.5). In conclusion, clinically diagnosed recurrent genital herpes during the third trimester of pregnancy associated with high risk for preterm birth.

Keywords

EN

Recurrent genital herpes; Gestational age at delivery; Preterm birth

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2011
• Volume: 6
• Issue: 4
• Pages: 449-455

Dates

published

1 - 8 - 2011

online

1 - 6 - 2011

Contributors

author

Ferenc Bánhidy

• Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, Üllői út 78/A, H-1082, Budapest, Hungary

author

István Dudás

• Foundation for the Community Control of Hereditary Diseases, Bolgárkerék utca 3, H-1148, Budapest, Hungary

author

Andrew Czeizel

• Foundation for the Community Control of Hereditary Diseases, Bolgárkerék utca 3, H-1148, Budapest, Hungary

References

• [1] Arvin A, Campadielli-Fiume G, Mocarski E, et al (eds.): Human Herpesviruses. Biology, Therapy, and Immunoprophylaxis. Cambridge University Press, Cambridge, 2007-04-17
• [2] Whitley RJ, Roizman B: Herpes simplex virus infection. Lancet 2001, 357, 1513–1518 http://dx.doi.org/10.1016/S0140-6736(00)04638-9[Crossref]
• [3] Cohen J: Painful failure of promising genital herpes vaccine. Science 2010, 330, 304 http://dx.doi.org/10.1126/science.330.6002.304[WoS][Crossref]
• [4] Brown ZA, Gardella C, Wald A et al: Genital herpes complicating pregnancy. Obstet Gynecol 2005, 106, 845–856 http://dx.doi.org/10.1097/01.AOG.0000180779.35572.3a[Crossref]
• [5] Brown ZA, Vontver LA, Benedetti J et al: Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987, 317, 1246–1250 http://dx.doi.org/10.1056/NEJM198711123172002[Crossref]
• [6] Brown ZA, Benedetti J, Selke S et al: Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: Relationship to preterm labor. Obstet Gynecol 1996, 87, 483–488 http://dx.doi.org/10.1016/0029-7844(95)00457-2[Crossref]
• [7] Vontver LA, Hickok DE, Brown ZA et al: Recurrent genital herpes simplex virus infection in pregnancy: Infant outcomes and frequency of asymptomatic recurrences Am J Obstet Gynecol 1982, 143, 75–84
• [8] Harger JH, Pazin GJ, Armstrong JA et al: Characteristics and management of pregnancy in women with genital herpes simplex virus infection. Am J Obstet Gynecol 1983, 145, 784–791
• [9] Catalano PM, Meritt AO, Mead PB: Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors. Am J Obstet Gynecol 1991, 164, 1303–1306
• [10] Boehm FH, Estes W, Wright PF, Growdon JF: Management of genital herpes simplex virus infection occurring during pregnancy. Am J Obstet Gynecol 1981, 141, 735–740
• [11] Proper C, Corey L, Brown ZA et al: The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992, 15, 1031–1038 http://dx.doi.org/10.1093/clind/15.6.1031[Crossref]
• [12] Czeizel AE, Rockenbauer M, Siffel Cs, Varga E: Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 2001, 63, 176–185 http://dx.doi.org/10.1002/tera.1032[Crossref]
• [13] Czeizel AE: The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997, 55, 299–305 http://dx.doi.org/10.1002/(SICI)1096-9926(199705)55:5<299::AID-TERA1>3.0.CO;2-V[Crossref]
• [14] Czeizel AE, Petik D, Vargha P: Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003, 12, 409–416 http://dx.doi.org/10.1002/pds.766[Crossref]
• [15] Czeizel AE, Vargha P: Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004, 191, 790–794 http://dx.doi.org/10.1016/j.ajog.2004.02.018[Crossref]
• [16] Xu F, Schillinger JA, Sternberg MR et al: Seroprevalence and co-infection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994. J Infect Dis 2002, 185, 1019–1924 http://dx.doi.org/10.1086/340041[Crossref]
• [17] Fleming DT, McGuillan GM, Johnson RE et al: Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997, 337, 1105–1111 http://dx.doi.org/10.1056/NEJM199710163371601
• [18] Pebody RG, Andrews N, Brown D et al: The seroepidemiology of herpes simplex virus types 1 and 2 in Europe, Sex Transm Infect 2004, 80, 185–191 http://dx.doi.org/10.1136/sti.2003.005850[Crossref]
• [19] Wald A, Zeh J, Selke S et al: Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995, 333, 770–775 http://dx.doi.org/10.1056/NEJM199509213331205[Crossref]
• [20] Czeizel AE: Ten years experience in periconceptional care. Eur J Obstet Gynecol Reprod Biol 1999, 84, 43–49 http://dx.doi.org/10.1016/S0301-2115(98)00246-2[Crossref]
• [21] Nahmias AJ, Lee FK, Bechman-Nahmias S: Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990, 69, 19–36
• [22] Sauerbrei A, Wutzler P: Serological detection of type-specific IgG to herpes simplex virus by novel ELISAs based on recombinant and highly purified glycoprotein G. Clin Lab 2004, 50, 425–429
• [23] ACOG Practice Bulletin: Management of herpes in pregnancy. Obstet Gynecol 2007, 109, 1489–1498 http://dx.doi.org/10.1097/01.AOG.0000263902.31953.3e[Crossref]
• [24] CCD. Sexually Transmitted Diseases Treatment Guidelines. MMWR 2006, 55, (no. RR-7)
• [25] Eskild A, Jeansson S, Hagen JA et al: Herpes simplex virus type 2 antibodies in pregnant women: the impact of the stage of pregnancy. Epidemiol Infect 2000, 125, 685–692 http://dx.doi.org/10.1017/S0950268800004702[Crossref]
• [26] Riley LE: Herpes simplex virus. Seminar Perinatol 1998, 22, 284–292 http://dx.doi.org/10.1016/S0146-0005(98)80017-7[Crossref]
• [27] Reeves WC, Corey L, Adams HG et al: Risk of recurrence after the first episode of genital herpes. Relation to HSV type and antibody response. N Engl J Med 1981, 305, 315–319 http://dx.doi.org/10.1056/NEJM198108063050604[Crossref]
• [28] Benedetti J, Corey L, Ashley RL: Recurrence rate in genital herpes after symptomatic first-episode infection. Ann Internal Med 1994, 121, 847–885
• [29] Brown ZA, Benedetti J, Ashley R et al: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991, 324, 1247–1352 http://dx.doi.org/10.1056/NEJM199105023241804[Crossref]
• [30] Jacobs RF: Neonatal herpes simplex virus infections. Semin Perinatpl 1998, 22, 64–71 http://dx.doi.org/10.1016/S0146-0005(98)80008-6[Crossref]
• [31] Rudnick CM, Hoekzema GS: Neonatal herpes simplex virus infections Am Famil Physician 2002, 65, 1138–1143
• [32] Gutierrez KM, Halpern MSF, Maldonado Y, Arvin AM: The epidemiology of neonatal herpes simplex infection in California from 1985 to 1995. J Infect Dis 1999, 180, 199–202 http://dx.doi.org/10.1086/314848
• [33] South MA, Thompkins WAF, Morris CR, Rawls WE: Congenital malformations of the central nervous system associated with genital type (type 2) herpes virus. J Pediatr 1969, 75, 13–15 http://dx.doi.org/10.1016/S0022-3476(69)80096-X[Crossref]
• [34] Florman AL, Gershon AA, Blackett PR, Nahmias AJ: Intrauterine infection with herpes simplex virus. Resultant congenital anomalies. J Am Med Ass 1973, 225, 129–132 http://dx.doi.org/10.1001/jama.225.2.129[Crossref]
• [35] Hutto C, Willett L, Yeager A, Whitely R: Congenital herpes simplex virus (HSV) infection. Early vs. late gestational acquisition. Pediatr Res 1985, 19, 296A http://dx.doi.org/10.1203/00006450-198504000-01144[Crossref]
• [36] Baldwin S, Whitley RJ: Intrauterine herpes simplex virus infection. Teratology 1989, 39, 1–10 http://dx.doi.org/10.1002/tera.1420390102[Crossref]
• [37] Brown ZA, Zelke S, Zeh J et al: Acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997, 337, 509–515 http://dx.doi.org/10.1056/NEJM199708213370801[Crossref]
• [38] Vasileiadis GT, Ronkema HW, Romano W et al: Intrauterine herpes simplex infection. Am J Perinatol 2003, 20, 55–58 http://dx.doi.org/10.1055/s-2003-38319[Crossref]
• [39] Monif GR, Kellner KR, Donnnelly WH Jr: Congenital herpes simplex type II infection. Am J Obstet Gynecol 1985, 152, 1000–1002
• [40] Avgil M, Ornoy A: Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol 106,21, 436–445 [PubMed]
• [41] Hutto C, Arvin A, Jacobs R et al: Herpes virus simplex virus and congenital malformations. South Med J 1983, 76, 1561–1563 http://dx.doi.org/10.1097/00007611-198312000-00026[Crossref]
• [42] Karesh JW, Kapur S, MacDonald M: Herpes simplex virus and congenital malformations. South Med J 1983, 76, 1561–1563 http://dx.doi.org/10.1097/00007611-198312000-00026[Crossref]
• [43] Kulhanjian J, Soroush V, Au D et al: Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992, 326, 916–920 http://dx.doi.org/10.1056/NEJM199204023261403[Crossref]
• [44] Ács N, Bánhidy F, Puho E, Czeizel AE: No association between maternal recurrent genital herpes in pregnancy and higher risk for congenital abnormalities, Acta Obstet Gynecol Scand 2008, 87, 292–299 http://dx.doi.org/10.1080/00016340801898943[Crossref][WoS]
• [45] Czeizel AE, Petik D, Vargha P: The reliability of retrospective maternal self-reported information concerning smoking and alcohol drinking pregnancy. Cent Eur J Publ Health 2004, 12, 179–183

Identifiers

DOI

10.2478/s11536-011-0044-y